ArticleFrontiers in immunology2024

Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study.

Yanli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.